VistaGen Therapeutics, Inc.
|
|||
Date: October 3, 2014
|
By:
|
/s/ Shawn K. Singh
|
|
Shawn K. Singh
|
|||
Chief Executive Officer
|
Exhibit Number
|
Description
|
|
10.1
|
Amendment No. 2 to Amended and Restated Note Conversion Agreement and Warrant Amendment, by and between VistaGen Therapeutics, Inc. and Platinum Long Term Growth VII, LLC, dated September 30, 2014.
|
ADDRESS:
|
VISTAGEN THERAPEUTICS, INC.
|
||
343 Allerton Avenue
South San Francisco, California 94080
|
|||
By:
/s/ Shawn K. Singh
Name: Shawn K. Singh
Title: Chief Executive Officer
|
|||
ADDRESS:
|
PLATINUM LONG TERM GROWTH VII, LLC
|
||
152 West 57
th
Street, 4
th
Floor
New York, NY 10019
|
|||
By:
/s/ Mark Nordlicht
Name: Mark Nordlicht
Title: Authorized Signatory
|
|||